These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 15337536

  • 21. A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
    Papagikos MA, Rossi PJ, Urbanic JJ, deGuzman AF, McCullough DL, Clark PE, Lee WR.
    Am J Clin Oncol; 2007 Apr; 30(2):199-204. PubMed ID: 17414471
    [Abstract] [Full Text] [Related]

  • 22. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
    Urology; 2005 Nov; 66(5):1048-53. PubMed ID: 16286122
    [Abstract] [Full Text] [Related]

  • 24. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Nov; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 25. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
    Seung SK, Kroll S, Wilder RB, Posner MD, Roach M.
    Cancer J Sci Am; 1998 Nov; 4(3):168-74. PubMed ID: 9612598
    [Abstract] [Full Text] [Related]

  • 26. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 27. Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy.
    Lee AK, Levy LB, Cheung R, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):456-62. PubMed ID: 15927415
    [Abstract] [Full Text] [Related]

  • 28. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
    Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):403-7. PubMed ID: 16765530
    [Abstract] [Full Text] [Related]

  • 29. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy.
    Green GA, Hanlon AL, Al-Saleem T, Hanks GE.
    Cancer; 1998 Sep 01; 83(5):971-6. PubMed ID: 9731902
    [Abstract] [Full Text] [Related]

  • 30. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy).
    Goldner G, Wachter S, Wachter-Gerstner N, Dieckmann K, Pötter R.
    Strahlenther Onkol; 2006 Sep 01; 182(9):537-42. PubMed ID: 16944376
    [Abstract] [Full Text] [Related]

  • 31. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG.
    Br J Cancer; 2002 Sep 23; 87(7):726-8. PubMed ID: 12232754
    [Abstract] [Full Text] [Related]

  • 32. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP.
    J Urol; 2001 Jan 23; 165(1):126-9. PubMed ID: 11125380
    [Abstract] [Full Text] [Related]

  • 33. Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192)Ir source, and neoadjuvant hormonal manipulation for prostate cancer.
    Izard MA, Haddad RL, Fogarty GB, Rinks A, Dobbins T, Katelaris P.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):38-47. PubMed ID: 16904516
    [Abstract] [Full Text] [Related]

  • 34. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.
    Urology; 2005 Jan 01; 65(1):95-100. PubMed ID: 15667872
    [Abstract] [Full Text] [Related]

  • 35. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
    Valicenti RK, Chervoneva I, Gomella LG.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1093-7. PubMed ID: 15001249
    [Abstract] [Full Text] [Related]

  • 36. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
    D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.
    Mol Urol; 2000 Mar 15; 4(3):171-5;discussion 177. PubMed ID: 11062371
    [Abstract] [Full Text] [Related]

  • 37. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 38. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer.
    Nguyen PL, Whittington R, Koo S, Schultz D, Cote KB, Loffredo M, Tempany CM, Titelbaum DS, Schnall MD, Renshaw AA, Tomaszewski JE, D'Amico AV.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):400-5. PubMed ID: 15145155
    [Abstract] [Full Text] [Related]

  • 39. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P.
    J Urol; 1998 Nov 01; 160(5):1722-6. PubMed ID: 9783940
    [Abstract] [Full Text] [Related]

  • 40. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    Cancer; 2009 Dec 01; 115(23):5596-606. PubMed ID: 19670452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.